Cambridge Investment Research Advisors
LFVN icon

Cambridge Investment Research Advisors’s LifeVantage LFVN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio LFVN Stock Details LFVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,957
Closed -$262K – 3904
2025
Q3 		$262K Buy
26,957
+16,352
+154% +$205K ﹤0.01% 3238
2025
Q2 		$139K Sell
10,605
-2,262
-18% -$29.2K ﹤0.01% 3430
2025
Q1 		$188K Buy
12,867
+2,421
+23% +$45.7K ﹤0.01% 3223
2024
Q4 		$183K Buy
+10,446
New +$146K ﹤0.01% 3213

Other funds holding LFVN

CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Cambridge Investment Research Advisors's LFVN Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of LifeVantage (LFVN) in Q4 2025, closing a stake of 26,957 shares — an estimated $262K sold.

Cambridge Investment Research Advisors first reported a position in LFVN in Q4 2024 and held it in 4 quarters. The position peaked at $262K in Q3 2025. 111 funds tracked by Wall St. Rank hold LFVN as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining LifeVantage position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 26,957 LifeVantage shares in Q4 2025, an estimated $262K.
  • Cambridge Investment Research Advisors first reported a position in LifeVantage in Q4 2024 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's LifeVantage position peaked at $262K in Q3 2025.
  • 111 funds tracked by Wall St. Rank held LifeVantage as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.